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Coronary reserve has been demonstrated to be within the 
normal range in long-term heart ransplant recipients without 
previous episodes of rejection (1). Conversely, acute cardiac 
allograft rejection is associated with a dramatic reduction i  
coronary flow reserve (2,3) that is fully restored soon after 
immunosuppressive therapy (4). However, the conse- 
quences of repeated rejection episodes on the coronary 
mtcrovasculature a  unknown. Rejection episodes might 
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induce progressive int rstitial fibrosis (5) and definitive mi- 
crovascular damage that decrease microvascular density. 
These pathophysiologic processes could gradually reduce 
the maximal area of the coronary microcirculation a d 
maximal coronary flow, thus decreasing coronary reserve. 
Such progressive deterioration of coronary microvascula- 
ture might be clinically relevant because heart transplant 
recipients frequently develop left ventricular hypertrophy (6) 
and accelerated coronary atherosclerosis (7-R)) that can 
further compromise myocardial perfusion. 
The present study was undertaken to assess the e 
time and previous episodes of rej 
microcirculation in human heart ra 
normal epicardial coronary arteries 
ular hypertrophy. Coronary vascular rese 
in the study patients I to 68 months after 
tion and the results were compared with findings in normal 
subjects. 
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patient selection. Because l ft ventricular hypertrophy in 
itself can cause reduced coronary flow reserve (111, the 
study group comprised only patients with normal left ven- 
tricular dimensions and systolic function and without left 
ventricular hypertrophy asassessed by two-dimensional and 
M-mode chocardiography erformed the day before catbe- 
terization (diastolic septal or posterior wall thickness 
<I cm). Transplant recipients and control subjects had 
normal findings on coronary arteriography and left ventric- 
ulography. Informed consent was obtained from each pa- 
tient. All studies were approved by an institutional medical 
committee. 
Tvnnspln~r gt~~rp. This group comprised 59 nonconsec- 
utive patients selected among 97 patients. The remaining 38
patients were excluded because of left ventricular hypertro- 
phy on echocardiography, irregular coronary vessels or 
coronary artery disease, elevated arterial pressure despite 
antihypertensive th rapy, or transplant rejection. Patients 
were studied between I to 68 months after transplantation 
and were classified into three groups with respect to time 
after transplantation: group I, n = 17 (1 to 6 months [mean 
5.0 & 1.71); group 2, n = 22 (7 to 18 months [mean 11.8 + 
2.8]), and group 3, n = 20 (> 18 months [mean 34.8 + 10.61). 
All patients were routinely evaluated for allograft rejec- 
tion by right ventricular endomyocardial biopsy performed 
according to previously described protocol (4). Results were 
graded according to the international classification (12). A 
rejection episode was defined by iopsy evidence of rejec- 
tion from its first appearance to resolved rejection proved by 
biopsy (13). Patients underwent right ventricular endomyo- 
cardial biopsy the day of catheterization. 
Immunosuppressive th rapy after transplantation com- 
prised prednisone and cyclosporine for all patients; 25 
patients (42%) also received azathioprine. Cyclosporine was 
titrated to maintain serum levels of 150 to 200 ng/ml during 
the 1st year after transplantation a d between 100 and 
150 @ml thereafter, as measured by nonspecific radioim- 
munoassay (Sandoz). 
C’on&~l subjects. This group comprised 16 patients who 
had recurrent atypical chest pain and equivocal results on 
either exercise treadmill testing or single-photon emission 
computed tomography (SPECT) thallium-201 scintigraphy. 
These subjects did not ake any medication. 
Catheterization protocol. Patients were in the fasting 
state for at least 12 h before the procedure. Administration f 
calcium channel blocking agents and arterial vasodilators 
was discontinued 24 h before the study. No premeditation 
was administered, and 1% lidocaine was used for local 
anesthesia. 
fight heart catheterization was performed only in trans- 
Plant recipients, who underwent pulmonary artery catheter- 
ization with a thermodilution catheter (Edwards Laborato- 
ries). Left heart catheterization was performed in all 
Patients. The Seldinger approach from a right femoral artery 
was used to place a 7F pigtail angiographic catheter into the 
left ventricle. Basal eft ventricular, aortic and right heart 
and pulmonary wedge pressures were recorded, and cardiac 
output was determined by the thermodilution merhod (Car- 
diac Output Computer model 9520 A, Edwards Laborato- 
ries). Heart rate, pressures and systemic vascular resistance 
were calculated by a catheterization data analysis computer 
system (model 5600 M, Hewlett-Packard) that f’:rformed 
on-line analysis of nine beats for averaging respiratory 
variations. 
Left ventriculography was performed with the use of 
30 ml of ioxaglate meglumine and an electrocardiogram 
(KS)-gated digita! su 
25 frames/s on a 256.pixel 
300), in a 30” iight anteri 
ular end-diastolic and end-systolic volu 
fraction were calculated by the a~c~-~c~~t 
ventricular mass was calculated accordi 
Rackley et al. (15). Arteriograms of each coronary artery 
were obtained in multiple projections after maximal epicar- 
dial artery vasodilation wasobtained by intracoronary injec- 
tion of 1.5 mg of isosorbide dinitrate (16). 
To evaluate coronary vasodilator reserve, we followed 
the procedure described by Wilson et al. (16,17) as previ- 
ously reported (4). Briefly, at least 15 min was allowed 
between the end of coronary arteriography and subsequent 
measurements. An 8F coronary guiding catheter was posi- 
tioned ir,to the left coronary artery, and maximal epicardial 
coronary vasodilation wasobtained by intracoronary injec- 
tion of 1.4 mg of is rbide dinitrate. A 3F 20MHz coronary 
Doppler catheter norail Doppler 3, Schneider Europe 
AG) connected to a single-channel 20-MHz pulsed Doppler 
velocimeter (model MDV-20 single-channel velocimeter, 
Millar Instruments) was positioned into the proximal seg- 
ment of the left anterior descending coronary artery. Mean 
and phasic oronary blood flow velocity (kHz), mean aortic 
pressure and an ECG were continuously recorded in the 
basal state and after injection of 12 mg of papaverine 
hydrochloride into the left anterior descending artery by the 
Doppler catheter. 
Coronary flow reserve was calculated as the peak/rest 
coronary flow velocity ratio (l6,17). To evaluate the altera- 
tion in coronary vascular resistance induced by intracoro- 
nary papaverine, a minimal coronary vascular esistance 
index was calculated as the quotient of mean aortic pressure 
at peak coronary flow velocity/peak coronary flow velocity 
and mean aortic pressure at rest coronary flow velocity/rest 
coronary flow velocity (17). 
Statistical analysis. All values are expressed as mean 
value +- SD. Statistical comparisons between groups were 
made by two-way analysis of variance followed by a modi- 
fied unpaired I test when one-way analysis of variance 
(ANOVA) detected a difference between groups. Bonferro- 
ni’s correction was performed to adjust the significance level 
according to the comparison umber. Relations between 
indexes of coronary reserve, time after surgery and number 
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Table atient CJtaracteristiss 
Minimal 
Age of PeakRest Coronar) 
Age of Cardiac Duration of No. of Coronary Vascular 
Patient Male/Female Donor Sschemia Hemoglobin Rejection Flow Velocity Resktance 
:yrb Ratio (yr) (min) @idI) Episodes/Patient Ratio Index 
Control subjects SO _+ 9 1412 - - 14.5 + 0.5 - 5.2 i 0.8 0.18 T 0.03 
(n = 16) 
Group 1 50 t IO Isi2 L7 ‘t 8 139 I 54 ii.9 2 0.8 1.4 * 1.4 5.3 rt 1.5 0.18 +r 0.04 
(II = 17) (p = NS) - - (p < 0.001) - (p = NS) tp = NS) 
Group 2 492 IO 1913 28 + 9 150 2 62 12.3 !I 1.0 2.5 2 1.9 4.9 + 1.2 0.20 + 0.06 
(n = 22) (p = NS) - - (p < 0.001) - (p = NS) (p = NS) 
Group 3 54 t IO 1713 252 II 127 + 48 12.4 + 0.7 2.1 2 1.3 4.4 f 1.6 0.23 i 0. I I 
(n = 20) (p = NS) - - (p < 0.001) - (p = NS) (p = NS) 
Values are expressed as mean values f. SD. p values compare each group of transplant patients with control subjects. 
of preview cpiscrdcs of rcjeciim were determixd by linear 
regression analysis using the least squares methQ 
cal difference was assumed if the null hypothesi 
rejected at the 0.05 probability level. 
le 1). The mean age of trans- 
plant patients and contrcjl subjects was similar. The mean 
age of cardiac donors, duration of allograft ischemia before 
transplantation acd hemoglobin concentration at the time of 
study were similar in the three grow 1s of transplant patients. 
Table 2. Hemodynamic and Angiographic Datd 
“1 P r^ns.r,.nr:, onevcF, hemcg6obrn caLIcL-YIlIuLL”n b”Ui( Jrp+YL&UYL’Y) .UIVLL %11”.- r:n”..:~n”dl,r In*.,n$. 
in transplant patients than in control subjects. 
ular mass. 
subjects. ,461 groups bad s 
is volume, ejection fractio 
There was a moderate elevation of mean aortic pressure 
in transplant groups 1 and 2 and of ieft ventricular systolic 
pressure in group 2 compared with values in control sub- 
jects. Left ventricular end-diastolic re was similar in 
the patients and control subjects. rate was signifi- 
p Value 
Control Group I Group I Group 2 
Subjects Group I Group 2 Group 3 Vb. vs. vs. 
(n = 16) (n = 17) (n = 22) (n = 20) Group 2 Group 3 Group 3 
HR (beatslmin) 76 ” 6 88 + 9 85 + 7 84t 12 NS NS NS 
(p < 0.001) (p < 0.01) (p < 0.05) 
Cl (literslmin per m*) - 2.9 ?r 0.6 3.0 r 0.8 2.8 2 0.6 NS NS NS 
- - - 
LVSP (mm Hg) 124 + 8 130 -c I5 136 2 17 124 ? 13 NS NS co.02 
(p = NS) (p < 0.02) (p = NS) 
LVEDP (mm Hg) 9k2 10 -c 3 10% 3 924 NS NS NS 
(p = NS) (p = NS) (p = NS) 
MRAP (mm Hg) - 322 1+2 4t2 NS NS NS 
- - - 
MAP fmm Hg) 97 2 8 105 1 10 106 + II 99 k 12 NS NS NS 
(p < 0.02) (p < 0.02) (p = NS) 
RPP 9.421 2 919 11,378 + 1,361 11,474 2 1,449 10,392 ? 1,900 NS NS co.05 
(p < 0.001) (p < 0.001) (p = NS) 
LVEDV (ml/m’) 79 + IO 80 i- 19 792 I5 762 13 NS NS NS 
(p = NS) (p = NS) (p = NS) 
EF (%) 67 2 7 67? II 66 4 7 6629 NS NS NS 
(p = NS) (p = NS) (7) = NS! 
LVM (g/m’) 82 k 9 9Ok I5 89+ 17 851: I2 NS NS NS 
(p = NS) (p = NS) (p = NS) 
Values are expressed as mean values k SD. p values in parentheses compare each group of transplant patients with control subjects. Cl = cardiac index 
EF = ejection fraction; HR = heart rate; LVEDP = left ventricular end-diastolic pressure: LVEDV = left ventricular end-diastolic volume; LVM = left 
ventricular mass; LVSP = left ventricular systolic pressure; MAP = mean aortic pressure; MRAP = mean right atrial pressure; RPP = rate-pressure product. 
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Figure I, Linear regression analysis of relations between indexes Figure 2. Linear regression analysis of relations between indexes 
of coronary reserve and time after heart transplanta!ion, show- of coronary reserve and the number of rejection episodes, show- 
ing the absence of correlation. Dotted lines represent the lower ing the absence of correlation. Dotted lines represent the lower 
limit of normal peak/rest coronary Row velocity ratio (normal limit of normal peak/rest coronary flow velocity ratio (normal 
mean - 2 SD = 3.6), and the upper limit of normal minimal coronary mean - 2 SD = 3.61, and the upper limit of normal minimal coronary 
vascular resistance index (normal mean t 2 SD = 0.24). vascu!ar resistance index (normal mean t 2 SD = 0.24). 
cantly higher in all transplant groups and rate-pressure 
product was elevated in groups I and 2. Comparisons among 
transplant groups howed a significant difference only be- 
tween the left ventricular systolic pressure and rate-pressure 
product of groups 2 and 3. 
Results of endomyocardial biopsy. The specimens from 
715 endomyocardial biopsies were analyzed. No rejection 
(Stade 0) was found in 336 biopsy specimens (47%). From 
the 379 histologically positive biopsy specimens, 141 rejec- 
tion episodes justifying augmented immunosuppressive ther- 
apy were diagnosed. The average number of rejection epi- 
sodes was similar inthe three groups of transplant patients 
(Table 1). Only two patients in group 2 and one patient in 
group 3 had no evidence of acute graft rejection. 
Coronary vasodilator reserve. Efect of time. Peak/rest 
coronary flow velocity ratio and minimal coronary vascular 
resistance index were not significantly different among trans- 
plant groups. These two variables were not statistically 
different from values in control subjects, whicrh were similar 
to those previously reported (16-18) (Table 1). There was no 
significant correlation between peak/rest coronary flow ve- 
locity or minimal coronary vascular resistance index and 
time after transplantation (Fig.1). Among the 59 transplant 
patients, 11 had a peak/rest coronary blood flow ratio below 
the lower limit of normal (mean - 2 SD = 3.6) (2 patients in 
&PUP 1, 3 patients in group 2 and 6 patients in group 3). 
Hemodynamic and angiographic data from these patients 
were Gmilar to those of patients with normal coronary 
reserve. 
Efict of previous episodes of rejection. There was no 
relation between the level of indexes of coronary reserve and 
the number of treated rejection episodes per patient in the 
total study group (Fig. 2). Particularly, indexes of coronary 
reserve were similar in patients with no or one episode of 
rejection, in patients with one or two episodes of rejection 
and in patients with four or more rejection episodes (Fig. 3). 
SSi 
ackgrouad. Provided that left ventricular hypertrophy 
was absent and coronary arteries were normal as demon- 
strated by angiography, coronary vasodilator reserve was 
previously shown to be preserved 1 to 5 years after heart 
transplantation in transplant recipients wi hout episodes of 
rejection (l), and within the 1st year after transplantation 
even in patients with previous episodes of rejection (19). 
Conversely, coronary reserve was found to be dramatically 
impaired uring acute rejection (2-4) but fully restored after 
rejection therapy (4). Nevertheless, repeated episodes of 
rejection might lead to definitive obstruction within the 
microvascular bed by thrombosis or obliterative intimal 
proliferation, or both (5,20), that gradually reduces maximal 
area of the coronary microcirculation and coronary reserve. 
Acute rejection could be responsible for focal myocardial 
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Figure 3. Indexes of coronary eserve in transplant patients accord- 
ing to the number of previous episodes of rejection. 
necrosis due to ischemia, and fibrotic tissue could result in 
extravascular compression of coronary microcirculation 
within the myocardium, which could reduce the number of 
functional vessels or impair the capacity of arteriolar vaso- 
dilation (5,21). However, most patients have only a small 
increase in interstitial collagen content (22). 
ng coronary reserve, time after traas~~anta- 
ti0 of rejection episodes. The main finding of
this study is that in a large series of human heart ransplant 
recipients with normal epicardial coronary arteries and with- 
out left ventricular hypertrophy, coronary vasodilator re- 
serve was preserved espite the occurrence of previous 
episodes of allograft rejection. There was no correlation 
between the number of previous rejection episodes and the 
level of coronary reserve. Furthermore, coronary reserve 
was similar in patients with four or more episodes of 
rejection and in patients with one or no previous episode of 
rejection. In addition, coronsry reserve. remained within the 
normal range irrespective of time after transplantation. 
However, the proportion of patients with a reduced coro- 
nary reserve was higher in group 3 (>18 months after 
transplantation) than in group 1. (1 to 6 months after trans- 
plantation) or group 2 (7 to 18 months after transplantation): 
30% versus 12% and 14%, respectively. As coronary reserve 
is evaluated through the maximaIibasal flow ratio, reduction 
to either an elevated ba 
ow, or both, in patients w
an increased basal coronary flow (23). In our study, hemo- 
globin level was sig~!~ca~~iy lower in tram paritrlls 
than in control subjects, but there was no rence in 
emoglobin levels between transplant patients with low or 
normai coronary reserve. 
Therefore, other mechanisms should be involved. I) 
biopsies are less frequently performed in older 
le !har nondiagnosed mild rejecFion 
terioration of coronary microcircula- 
yclosporine could reduce blood w after 
on (24,25), it also could progress ly alter 
nary reserve. Cycles 
steroids, has been associated with 
edema nd fibrosis (
(22) failed to find a s 
dial collagen content and cyclosporine therapy. Cy 
ine could otherwise alter coronary response to vasodilators 
(24,25). 3) Accelerated coronary graft atherosclerosis due to 
red~isolo~e therapy frequently develops 
in both epicardial rteries and arterioles after heart rans- 
plantation (7-l&27). Although &inn et al. (1) found no 
impairment of maximal coron hyperemia in transplant 
patients with mild to moderate large vessel cororiary ather- 
I), their study included only patients with regular 
owever, the predominantly distal and diffuse 
concenlric narrowings make initial lesions difficult o be 
appreciated bystandard, nonquantitative coronary angiog- 
raphy (a$), and intimal thickening on intracoronary ultra- 
sound imaging has been shown in most patients e 1 year after 
transplantation (29). Moreover, graft vascular lesions can be 
confined to small coronary arteries and arterioles and there- 
fore may not be detectable by coronary angiography (30). 
Such lesions could have played a role in patients with 
reduced coronary reserve. 
ethodologic ~imi~t~ons. Coronary reserve has become 
widely accepted as an indicator of the physiologic signifi- 
cance of pathologic conditions affecting he coronary circu- 
lation. The evaluation ofcoronary reserve by the Doppler- 
papaverine method is now a standardized procedure, 
accurate, reproducible and easy to perform (31,32). Core- 
nary reserve was estimated through the peakjrest coronary 
flow velocity ratio and by a minimal coronary vascular 
resistance index that takes into account aortic pressure 
alterations induced by ia?racoronary papaverine (17). This 
technique, although extensively validated, oes not allow 
determination f whether a reduction of coronary reserve is
due to increased flow at rest or decreased maximal flow,or 
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both (17). In addition, this method postulates that papaver- 
ine does not dilate epicardial v:ssels over the level of 
dilation caused by intracoronary iiiosorbide dinitrate, mak- 
ing the changes inthe velocity a re; ction of changes in flow 
(l&17.31,32). 
At the time of study, our patient groups had no hyperten- 
sion or left ventricl;lar hypertrophy and had normal epicar- 
dial coronary arteries. In clinical practice, arterial hyperten- 
sion is frequently observed in transplant recipients (33-35), 
left ventricular hypertrophy is a frequent echocardiographic 
finding (6) and approximately 50% of transplant patients 
develop coronary artery lesic-as by 5 years after transplan- 
tation (9). All these conditions are major determinants of 
coronary reserve impairment. 
Finally, coronary reserve was not measured at different 
times in the same patient in our study. This procedure might 
provide more meaningful data about he effect of time on 
coroflnry reserve. 
conclusions. The present study shows that coronary 
vasodilator capacity remains within the normai range until 
late after heart transplantation despite intervening episodes 
of acute allograft rejection. This finding indicates that coro- 
nary microvasculature is not significantly affected by time 
and immunosuppressive therapy in patients without evolving 
rejection at the time of determination, Furthermore, the 
number of previous episodes of rejection does not appear to 
affect he level of coronary reserve. However some patients 
with angiographically normal coronary arteries have a sig- 
nificant reduction of coronary reserve, whose origin de- 
serves further investigation. 
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